BERRY GENOMICS(SZ:000710)2022-12-07 09:06Group 1: Company Overview - Chengdu Tianxing Instrument Co., Ltd. focuses on the development, production, and sales of hospital infection control equipment and provides comprehensive solutions for Central Sterile Supply Departments (CSSD) [3] - The company will maintain dual business operations in automotive instruments and hospital infection control equipment after restructuring [3][4] Group 2: Restructuring and Business Strategy - The restructuring plan is currently under review by the China Securities Regulatory Commission, and no new projects are being considered at this time [4] - The major shareholder's frozen shares do not affect the company's normal operations, and efforts are being made to resolve financial disputes [4][5] - Tianxing Group holds a controlling stake of 58.86% in Tianxing Instrument, with a market value of approximately 1.188 billion yuan as of March 6, 2015 [4][5] Group 3: Management and Operations - Post-restructuring, the original management team of Aoken Medical will continue to manage daily operations, with Tianxing Instrument appointing directors and financial leaders [5] - Aoken Medical has ongoing contracts and orders, details of which are available in the company's public announcements [5]